Allspring Global Investments’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
RIM
Allspring Global Investments's IRMD Position: Q2 2025 in Review
Allspring Global Investments sold out of iRadimed (IRMD) in Q2 2025, closing a stake of 20,227 shares — an estimated $1.06M sold.
Allspring Global Investments first reported a position in IRMD in Q4 2021 and held it in 14 quarters. The position peaked at $2.52M in Q1 2022. 162 funds tracked by Wall St. Rank hold IRMD as of Q2 2025.
- Allspring Global Investments reported no remaining iRadimed position as of Q2 2025 after selling out during the quarter.
- Allspring Global Investments sold 20,227 iRadimed shares in Q2 2025, an estimated $1.06M.
- Allspring Global Investments first reported a position in iRadimed in Q4 2021 and held it in 14 quarters.
- Allspring Global Investments's iRadimed position peaked at $2.52M in Q1 2022.
- 162 funds tracked by Wall St. Rank held iRadimed as of Q2 2025.
Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.